XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.3

Schedule of Contractual Clinical Trials (Details)	9 Months Ended
	Sep. 30, 2024 USD ($) Integer
Other Commitments [Line Items]
Remaining financial contractual commitment | $	$ 3,616,000
Phase 1b [Member]
Other Commitments [Line Items]
Clinical trial, description	LB-100 combined with atezolizumab in microsatellite stable metastatic colon cancer
Estimated Start Date	August 2024
Estimated End Date	December 2026
Number of Patients in Trial | Integer	37
Expected Date	June 2026
Remaining financial contractual commitment | $		[1]
Phase 1b Two [Member]
Other Commitments [Line Items]
Clinical trial, description	LB-100 combined with doxorubicin in advanced soft tissue sarcoma
Estimated Start Date	June 2023
Estimated End Date	Recruitment completed September 2024
Expected Date	March 2025
Remaining financial contractual commitment | $	$ 284,000
Phase 1b Two [Member] | Minimum [Member]
Other Commitments [Line Items]
Number of Patients in Trial | Integer	9
Phase 1b Two [Member] | Maximum [Member]
Other Commitments [Line Items]
Number of Patients in Trial | Integer	18
Randomized Phase 2 [Member]
Other Commitments [Line Items]
Clinical trial, description	Doxorubicin with or without LB-100 in advanced soft tissue sarcoma (Randomized
Number of Patients in Trial | Integer	150
Expected Date	December 2026
Remaining financial contractual commitment | $	$ 3,332,000
Clinical Trial Phase MD 1b 2 [Member]
Other Commitments [Line Items]
Clinical trial, description	LB-100 combined with dostarlimab in ovarian clear cell carcinoma
Estimated Start Date	January 2024
Estimated End Date	December 2027
Number of Patients in Trial | Integer	21
Expected Date	December 2026
Remaining financial contractual commitment | $		[1]
[1] The Company has no financial contractual commitment associated with this clinical trial at September 30, 2024.

X

- Definition

Clinical trial description.

+ References

No definition available.

+ Details

Name:	LIXT_ClinicalTrialDescription
Namespace Prefix:	LIXT_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Contractual clinical trial period end date

+ References

No definition available.

+ Details

Name:	LIXT_ContractualClinicalTrialPeriodEndDate
Namespace Prefix:	LIXT_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Contractual clinical trial period start date.

+ References

No definition available.

+ Details

Name:	LIXT_ContractualClinicalTrialPeriodStartDate
Namespace Prefix:	LIXT_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Expected date of preliminary efficacy signal.

+ References

No definition available.

+ Details

Name:	LIXT_ExpectedDateOfPreliminaryEfficacySignal
Namespace Prefix:	LIXT_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of patient in trial.

+ References

No definition available.

+ Details

Name:	LIXT_NumberOfPatientInTrial
Namespace Prefix:	LIXT_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_OtherCommitmentsAxis=LIXT_ClinicalTrialPhase1bMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_OtherCommitmentsAxis=LIXT_ClinicalTrialPhase1bTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_OtherCommitmentsAxis=LIXT_ClinicalTrialRandomizedPhaseTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_OtherCommitmentsAxis=LIXT_ClinicalTrialPhaseMD1b2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: